Document is current
Any future updates will be listed below
-
Authors
Demirjian, Sevag
Huml, Anne
Bakaeen, Faisal
Poggio, Emilio
Geube, Mariya
Shaw, Andrew
Gillinov, A. Marc
Gadegbeku, Crystal A.
-
Funding
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (U01DK129980.)
National Institute of Diabetes and Digestive and Kidney Diseases (U01DK129980.)
National Institute of Diabetes and Digestive and Kidney Diseases (U01DK129980.)
- License Information
-
More Information
Article History
Received: 24 November 2023
Accepted: 15 May 2024
First Online: 22 May 2024
Declarations
:
: The Cleveland Clinic Institutional Review Board provided Ethics approval and waived the needfor informed consent due to low risk and observational nature of the study.
: Granted.
: Dr. Demirjian and Cleveland Clinic Innovations Center hold U.S. Patent for predictive models for CS-AKI. Dr. Gillinov reports consultation services to Edwards, Medtronic, Artivion, Abbott, ClearFlow, and AtriCure. No other disclosures reported.
